| Patents for C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof (42,273) |
|---|
| 01/11/2001 | WO2001002428A1 Process for the preparation of lh-rh derivatives |
| 01/11/2001 | WO2001002018A2 Compounds that associate on the intermolecular level and aggregate bodies that contain them |
| 01/11/2001 | WO2001002001A1 PEPTIDE LIGANDS THAT BIND IgM ANTIBODIES AND BLOCK INTERACTION WITH ANTIGEN |
| 01/11/2001 | WO2001001749A2 FVIIa ANTAGONISTS |
| 01/11/2001 | WO2001001748A2 Peptide compounds that bind her2 |
| 01/11/2001 | WO2000063233A3 Peptides and the use thereof to control pests |
| 01/11/2001 | WO2000056345A3 Methods for limiting scar and adhesion formation |
| 01/11/2001 | DE19930177A1 Intermolekular assoziierende Verbindungen und diese umfassende Aggregate Inter-molecular compounds and associating this comprehensive aggregates |
| 01/11/2001 | CA2373735A1 Fviia antagonists |
| 01/10/2001 | EP1066390A2 Methods of cancer diagnosis using a chimeric toxin |
| 01/09/2001 | US6172194 ARF-p19, a novel regulator of the mammalian cell cycle |
| 01/09/2001 | US6172192 Polypeptide or peptide associated microorganism infection; for diagnosis and prevention protozoan infection of mammals |
| 01/09/2001 | US6172185 Antimicrobial cationic peptide derivatives of bactenecin |
| 01/09/2001 | US6172043 Treatments for neurotoxicity in Alzheimer's disease caused by β amyloid peptides |
| 01/09/2001 | US6172041 Nervous system disorders |
| 01/09/2001 | US6171846 Culturing cells which are blocked in the synthesis of virginimycins; mutating genes in target microorganism and recovering cells with mutated target genes |
| 01/09/2001 | US6171806 Isolated peptide defined by SEQ ID NO: 17 and uses thereof |
| 01/09/2001 | US6171612 Gene therapy |
| 01/09/2001 | US6171577 Accessible sulfhydryl group; and hexose moiety recognized by a mammalian liver receptor, wherein the hexose moiety is conjugated to the annexin. |
| 01/09/2001 | CA2192079C Human monoclonal antibodies specific to cell cycle independent glioma surface antigen |
| 01/04/2001 | WO2001001140A1 Epitopes formed by non-covalent association of conjugates |
| 01/04/2001 | WO2001000851A1 Cyclic amp phosphodiesterase isoforms and methods of use |
| 01/04/2001 | WO2001000676A1 Somatostatin agonists |
| 01/04/2001 | WO2001000670A1 Bh3 modified peptides |
| 01/04/2001 | WO2001000660A1 INHIBITORS OF THE INTEGRIN αvβ¿6? |
| 01/04/2001 | WO2001000655A2 Therapeutic peptides derived from subsequences of bpi |
| 01/04/2001 | WO2001000247A1 Peptide-lipid conjugates, liposomes and liposomal drug delivery |
| 01/04/2001 | WO2001000225A1 Hla binding peptides and their uses |
| 01/04/2001 | WO2001000224A1 Compositions and methods for treatment of sexual dysfunction |
| 01/04/2001 | WO2000063237A3 Pseudomycin analogs |
| 01/04/2001 | CA2377484A1 Cyclic amp phosphodiesterase isoforms and methods of use |
| 01/04/2001 | CA2377265A1 Somatostatin agonists |
| 01/04/2001 | CA2377224A1 Inhibitors of the integrin .alpha.v.beta.6 |
| 01/04/2001 | CA2376859A1 Peptide-lipid conjugates, liposomes and liposomal drug delivery |
| 01/04/2001 | CA2370413A1 Hla binding peptides and their uses |
| 01/04/2001 | CA2370099A1 Bh3 modified peptides |
| 01/03/2001 | EP1065212A2 Lipopeptide inducing T-cytotoxic lymphocytes and their use as vaccines |
| 01/03/2001 | EP1064308A1 Methods for identifying inducers and inhibitors of proteolytic antibodies, compositions and their uses |
| 01/03/2001 | EP1064300A1 Peptide turn mimetics |
| 01/03/2001 | EP1064299A1 Cyclohexapeptide wf14573 or its salt, production thereof and use thereof |
| 01/03/2001 | EP1064022A1 Hla-binding peptides and their uses |
| 01/03/2001 | EP1064010A1 Peptide compositions and formulations and use of same |
| 01/03/2001 | EP0815126B1 Bicyclic tachykinins antagonists, preparation thereof and their use in pharmaceutical composition |
| 01/03/2001 | CN1278829A Apeptide with an affinity for clotting factor VIII |
| 01/03/2001 | CN1278734A Methods and compositions for treating rheumatoid arthritis |
| 01/03/2001 | CN1060178C Derivatives of structurally modified vip and pharmacetical compositions containing them for treating servual impotense of male |
| 01/02/2001 | US6169072 Cyclic adhesion inhibitors |
| 01/02/2001 | US6169071 Compounds and methods for modulating cell adhesion |
| 01/02/2001 | US6168791 Antibodies that bind immunomodulators |
| 01/02/2001 | CA2114156C Elucidation and synthesis of selected pentapeptides |
| 01/02/2001 | CA2034979C Antibiotic, deoxymulundocandin, a process for its production and its useas medicament |
| 12/28/2000 | WO2000079284A1 Cartilage resorption assays |
| 12/28/2000 | WO2000078956A1 Novel pyrrhocoricin-derived peptides, and methods of use thereof |
| 12/28/2000 | WO2000078806A1 Mage-a1 peptides presented by hla class ii molecules |
| 12/28/2000 | WO2000078805A1 Peptide having preptin functionality |
| 12/28/2000 | WO2000078801A2 Insulin-like growth factor agonist molecules |
| 12/28/2000 | WO2000078798A1 Process for the isolation of rufomycin factors |
| 12/28/2000 | WO2000078797A1 Rufomycin derivatives useful as antibiotics |
| 12/28/2000 | WO2000078796A2 Labeled neurotensin derivatives with improved resistance to enzymatic degradation |
| 12/28/2000 | WO2000078795A2 Rufomycins and derivatives thereof useful as inhibitors of multi-drug resistance associated protein-1 (mrp-1) |
| 12/28/2000 | WO2000078793A2 Antimicrobial agents |
| 12/28/2000 | WO2000078344A1 Prion protein peptides and uses thereof |
| 12/28/2000 | WO2000056353A3 A uro-genital condition treatment system |
| 12/28/2000 | WO2000034315A3 Purification of echinocandin cyclopeptide compounds |
| 12/28/2000 | DE19929410A1 New octapepide compounds as alpha v beta 6 integrin inhibitors useful for treating and diagnosing heart disease, tumors, osteoporosis, fibrosis, inflammation, infection and psoriasis |
| 12/28/2000 | CA2377648A1 Prion protein peptides and uses thereof |
| 12/28/2000 | CA2375502A1 Novel pyrrhocoricin-derived peptides, and methods of use thereof |
| 12/28/2000 | CA2375207A1 Peptide having preptin functionality |
| 12/28/2000 | CA2374270A1 Labeled neurotensin derivatives |
| 12/27/2000 | EP1062232A2 Molecules that home to various selected organs or tissues |
| 12/27/2000 | EP1062229A1 Pharmacologically active peptide conjugates having a reduced tendency towards enzymatic hydrolysis |
| 12/27/2000 | EP1061937A1 Improved radiation therapy methods |
| 12/27/2000 | EP1061935A1 Proapoptotic peptides, dependence polypeptides and methods of use |
| 12/27/2000 | EP0804483B1 Isolated peptides derived from mage tumor rejection antigen precursors which complex with hla-a2 molecules |
| 12/26/2000 | US6166178 Polypeptide for the treatment of cancer; anticarcinogenic agents |
| 12/26/2000 | US6165978 Wound healing composition |
| 12/26/2000 | US6165787 Regulated transcription of targeted genes and other biological events |
| 12/26/2000 | US6165730 Amino acid sequences of epitopes; for immunoassay diagnosis and immunogens for vaccines |
| 12/26/2000 | US6165717 Method of synthesizing diverse collections of oligomers |
| 12/21/2000 | WO2000077194A1 A structured peptide scaffold for displaying turn libraries on phage |
| 12/21/2000 | WO2000077033A1 Retro-inverso peptides derived from interleukin-6 |
| 12/21/2000 | WO2000077031A2 Muc1 ligands |
| 12/21/2000 | WO2000077030A1 Statine-derived tetrapeptide inhibitors of beta-secretase |
| 12/21/2000 | WO2000077029A1 Retro-inverso peptides derived from leukemia inhibitory factor |
| 12/21/2000 | WO2000077028A1 Retro-inverso peptides derived from interleukin-3 |
| 12/21/2000 | WO1998021230A8 Cyclic peptides that bind to urokinase-type plasminogen activator receptor |
| 12/21/2000 | CA2376479A1 Retro-inverso peptides derived from interleukin-6 |
| 12/21/2000 | CA2376474A1 Retro-inverso peptides derived from leukemia inhibitory factor |
| 12/21/2000 | CA2376420A1 Statine-derived tetrapeptide inhibitors of beta-secretase |
| 12/21/2000 | CA2376394A1 Retro-inverso peptides derived from interleukin-3 |
| 12/21/2000 | CA2376232A1 A structured peptide scaffold for displaying turn libraries on phage |
| 12/20/2000 | EP1060249A1 Epitope peptides immunogenic against streptococcus pneumoniae |
| 12/20/2000 | EP0823848A4 Tissue adhesive using synthetic cross-linking |
| 12/20/2000 | EP0761682B1 Cyclodepsipeptides |
| 12/19/2000 | US6162902 Reactive to epitopes of human brain natriuretic peptide; rapid and sensitive quantification in plasma or serum |
| 12/19/2000 | US6162439 An isolated polypeptides derived from novel lentiviruses for the detection of aids |
| 12/19/2000 | CA2145881C Anti-inflammatory, tolerogenic and immunoinhibiting properties of carbohydrate binding-peptides |
| 12/19/2000 | CA2000420C Peptides representing epitopic sites on r-ifn-beta, antibodies thereto, and uses thereof |
| 12/14/2000 | WO2000075664A1 Improvements in luminescence polarization assays |
| 12/14/2000 | WO2000075662A1 Cell-signaling assays |